患者様やご家族など一般の方向け臨床・治癒情報サイト　臨床研究情報ポータルサイト

• 進捗状況
• 試験名
• 対象疾患名
• 地域
• 登録日
•  

• Not Recruiting

• Study of AVE5026 at weight-adjusted doses in children with a Central Venous Line
• Prevention of thromboembolism MedDRA version: 14.1 Level: LLT Classification code 10043566 Term: Thromboembolism System Organ Class: 10047065 - Vascular disorders ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
• Brazil, Canada, Guatemala, Hong Kong, Hungary, Israel, Mexico, Peru, Romania, Russian Federation, Singapore, Slovakia, Spain, Switzerland, Turkey
• 2012-02-06

• Recruiting

• Temsirolimus as Second-line Therapy in HCC
• Unresectable or Metastatic Hepatocellular Carcinoma
• United States
• 2012-02-01

• Not recruiting

• JUVEDERM® Ultra XC vs. Belotero Balance® for Perioral Lines
• Patients With Moderate to Severe Perioral Lines;Patients With Moderate to Severe Perioral Lines;Patients With Moderate to Severe Perioral Lines;Patients With Moderate to Severe Perioral Lines
• United States
• 2013-10-23

• Recruiting

• A Pilot Treatment Study of Insulin-Like Growth Factor-1 (IGF-1) in Autism Spectrum Disorder
• Autism Spectrum Disorder
• United States
• 2013-10-22

• Not recruiting

• CHG Dressings in Children With Central Lines
• Children With Central Venous Access
• United States
• 2013-09-24

• Not recruiting

• Efficacy and Safety of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
• Skin Aging
• United States
• 2013-09-09

• Not recruiting

• Virtual Reality With Ultrasound Versus Ultrasound For Central Line Insertion
• Central Line Complication
• Canada
• 2013-06-09

• Recruiting

• Regorafenib Plus Pembrolizumab in First Line Systemic Treatment of HCC
• Carcinoma, Hepatocellular
• Germany, United States
• 2017-11-16

• Recruiting

• Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition
• Diabetes Mellitus, Type 2;Pre-diabetic;Hypertension;Elevated Blood Pressure
• United States
• 2017-11-07

• Not recruiting

• University of Southern California Choreographic Institute Line Dance Study
• Quality of Life;Quality of Life;Quality of Life
• United States
• 2017-10-31

• Recruiting

• Ziconotide as First-Line IDT
• Neuropathic Pain Secondary to a Clear Etiology;Neuropathic Pain Secondary to a Clear Etiology;Neuropathic Pain Secondary to a Clear Etiology;Neuropathic Pain Secondary to a Clear Etiology
• United States
• 2017-10-19

• Not Recruiting

• Pembrolizumab plus epacadostat, pembrolizumab monotherapy, and the EXTREME regimen as first line treatment for R/M HNSCC (KEYNOTE-669/ECHO-304)
• Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma MedDRA version: 20.0 Level: PT Classification code 10060121 Term: Squamous cell carcinoma of head and neck System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
• Australia, Austria, Brazil, Canada, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Mexico, Poland, Portugal, Spain, Taiwan, Turkey, United Kingdom, United States
• 2017-10-10

• Recruiting

• Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer
• Pancreatic Neoplasm;Pancreatic Neoplasm;Pancreatic Neoplasm
• Taiwan, United States
• 2017-10-01

• Recruiting

• CRF - Nociceptin Receptor Interactions
• Healthy
• United States
• 2017-09-29

• Recruiting

• Virtual Reality Distraction During Pediatric Intravenous Line Placement
• Pediatric IV Placement;Virtual Reality Distraction;Pediatric IV Placement;Virtual Reality Distraction;Pediatric IV Placement;Virtual Reality Distraction;Pediatric IV Placement;Virtual Reality Distraction
• United States
• 2017-09-28

• Not recruiting

• Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults
• HIV Infections;HIV Infections
• Argentina, Australia, Canada, France, Germany, Italy, Korea, Republic of, Mexico, Russian Federation, South Africa, Spain, Sweden, United States
• 2017-09-26

• Not recruiting

• A Study to Evaluate the Efficacy and Safety of (D/C/F/TAF) Once Daily Fixed Dose Combination (FDC) Regimen in Newly Diagnosed, Antiretroviral Treatment-naive Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Receiving Care in a Test and Treat Model of Care
• HIV-1
• United States
• 2017-07-21

• Not recruiting

• Oral Calcitriol With Ketoconazole in CRPC
• Castration-resistant Prostate Cancer
• United States
• 2017-07-12

• Recruiting

• An EPIC Based BPA to Enhance Quit Line Referral and Use
• Smoking Cessation
• United States
• 2017-07-11

• Not recruiting

• Avelumab in First-line Non-Small Cell Lung Cancer (JAVELIN Lung 100)
• First Line Non-Small Cell Lung Cancer
• Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Cyprus, Czech Republic, Czechia, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Lebanon, Lithuania, Mexico, Netherlands, New Zealand, Peru, Poland, Portugal, Romania, Russian Federation, Serbia, Singapore, Slovakia, South Africa, Spain, Taiwan, Thailand, Turkey, Ukraine, United Kingdom, United States
• 2015-10-13